GFAP and neurodegenerative disease: The use of β-lactam antibiotic ceftriaxone as a potential drug to ameliorate neurodegenerative diseases was studied using GFAP and lysozyme showing that the presence of ceftriaxone could reduce significantly the rate of UV photodenaturation of the proteins (Figure 3a).